{"disease":{"id":"dengue-vaccines","name":"dengue vaccines"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06898775","title":"Passive Safety Surveillance Data of Dengue Vaccine, Qdenga (TAK 003) in Private Vaccination Sites in Buenos Aires, Argentina.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":112345,"lead_sponsor_name":"Fundación Vacunar","has_results":false},{"nct_id":"NCT02766088","title":"This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia","phase":"NA","overall_status":"TERMINATED","enrollment_count":1750,"lead_sponsor_name":"GlaxoSmithKline","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}